We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
+29.68%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$657M
AUM Growth
+$129M
Cap. Flow
-$12M
Cap. Flow %
-1.83%
Top 10 Hldgs %
96.41%
Holding
16
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CRGX
CARGO Therapeutics
CRGX
+$10.9M
2
SPRY icon
ARS Pharmaceuticals
SPRY
+$1.16M
3
MRSN
Mersana Therapeutics
MRSN
+$8

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.6B
$355M 54.03%
7,601,087
– –
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.2B
$86M 13.08%
7,162,637
– –
TYRA icon
3
Tyra Biosciences
TYRA
$1.84B
$56.7M 8.64%
4,055,861
– –
TNGX icon
4
Tango Therapeutics
TNGX
$4.21B
$46.5M 7.08%
5,533,980
– –
RLAY icon
5
Relay Therapeutics
RLAY
$4.01B
$20.1M 3.06%
3,846,409
– –
KYMR icon
6
Kymera Therapeutics
KYMR
$8.71B
$19.3M 2.94%
340,909
– –
ZYME icon
7
Zymeworks
ZYME
$1.62B
$19M 2.9%
1,113,946
– –
ARVN icon
8
Arvinas
ARVN
$535M
$12M 1.83%
1,408,394
– –
ALMS
9
Alumis Inc
ALMS
$3.36B
$11.6M 1.77%
2,915,998
– –
CNTX icon
10
Context Therapeutics
CNTX
$54.2M
$7.19M 1.09%
7,419,355
– –
CGEM icon
11
Cullinan Oncology
CGEM
$1.04B
$6.77M 1.03%
1,141,145
– –
SPRY icon
12
ARS Pharmaceuticals
SPRY
$574M
$6.64M 1.01%
660,703
-81,026
-11% -$1.16M
SLN
13
Silence Therapeutics
SLN
$540M
$4.94M 0.75%
952,400
– –
MRSN
14
DELISTED
Mersana Therapeutics
MRSN
$3.75M 0.57%
482,689
-1
-0% -$8
BOLD
15
Boundless Bio
BOLD
$55.7M
$1.51M 0.23%
1,228,069
– –
CRGX
16
DELISTED
CARGO Therapeutics
CRGX
– –
-2,642,502
Closed -$10.9M

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q3 2025 Portfolio in Review

As of Q3 2025, Nextech Invest held 16 positions worth $657M, up 24% from $528M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Nextech Invest's Q3 2025 filing shows 2 reduced and 1 closed positions. The largest sale was CARGO Therapeutics, an estimated $10.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Nextech Invest's biggest Q3 2025 reduction was ARS Pharmaceuticals, cutting an estimated $1.16M.
  • Nextech Invest fully exited CARGO Therapeutics in Q3 2025, selling an estimated $10.9M.
  • Nextech Invest's ten largest holdings make up 96% of its $657M portfolio in Q3 2025.
  • Nextech Invest opened 0 new positions and closed 1 in Q3 2025.
  • Nextech Invest's portfolio value rose 24% quarter-over-quarter to $657M.

Based on Nextech Invest's 13F filing for Q3 2025, filed 14 Nov 2025.